111 related articles for article (PubMed ID: 16549578)
1. Best evidence topic report. Gammahydroxybutyrate overdose and physostigmine.
Allen L; Alsalim W
Emerg Med J; 2006 Apr; 23(4):300-1. PubMed ID: 16549578
[No Abstract] [Full Text] [Related]
2. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?
Caldicott DG; Kuhn M
Ann Emerg Med; 2001 Jan; 37(1):99-102. PubMed ID: 11145779
[TBL] [Abstract][Full Text] [Related]
3. Use of physostigmine in the management of gamma-hydroxybutyrate overdose.
Boyer EW; Quang L; Woolf A; Shannon M
Ann Emerg Med; 2001 Sep; 38(3):346; author reply 347-8. PubMed ID: 11524662
[No Abstract] [Full Text] [Related]
4. The use of physostigmine in the management of gamma-hydroxybutyrate overdose.
Mullins ME; Dribben W
Ann Emerg Med; 2001 Sep; 38(3):347-8. PubMed ID: 11547795
[No Abstract] [Full Text] [Related]
5. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
6. Physostigmine in the treatment of gamma-hydroxybutyric acid overdose.
Yates SW; Viera AJ
Mayo Clin Proc; 2000 Apr; 75(4):401-2. PubMed ID: 10761496
[TBL] [Abstract][Full Text] [Related]
7. Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review.
Traub SJ; Nelson LS; Hoffman RS
J Toxicol Clin Toxicol; 2002; 40(6):781-7. PubMed ID: 12475191
[TBL] [Abstract][Full Text] [Related]
8. Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent?
Mullins ME; Dribben W
Mayo Clin Proc; 2000 Aug; 75(8):871-2; author reply 872-3. PubMed ID: 10943249
[No Abstract] [Full Text] [Related]
9. The use of physostigmine in diphenhydramine overdose.
Padilla RB; Pollack ML
Am J Emerg Med; 2002 Oct; 20(6):569-70. PubMed ID: 12369036
[No Abstract] [Full Text] [Related]
10. "Fantasy"-drug of abuse.
Holmes CM
N Z Med J; 2000 Apr; 113(1107):129. PubMed ID: 10834284
[No Abstract] [Full Text] [Related]
11. Best evidence topic report: endotracheal intubation in gamma-hydroxybutyric acid intoxication and overdose.
Michael H; Harrison M
Emerg Med J; 2005 Jan; 22(1):43. PubMed ID: 15611542
[TBL] [Abstract][Full Text] [Related]
12. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
Bania TC; Chu J
Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
[TBL] [Abstract][Full Text] [Related]
13. Physostigmine as treatment for severe CNS anticholinergic toxicity.
Teoh R; Page AV; Hardern R
Emerg Med J; 2001 Sep; 18(5):412. PubMed ID: 11559630
[No Abstract] [Full Text] [Related]
14. The use of amphetamine in gamma-hydroxybutyrate overdose: a case report.
Kohrs FP; Mann C; Greenberg R
J Psychoactive Drugs; 2004 Sep; 36(3):401-2. PubMed ID: 15559687
[TBL] [Abstract][Full Text] [Related]
15. Reversal of quetiapine-induced altered mental status with physostigmine: a case series.
Cole JB; Stellpflug SJ; Ellsworth H; Harris CR
Am J Emerg Med; 2012 Jul; 30(6):950-3. PubMed ID: 21802878
[TBL] [Abstract][Full Text] [Related]
16. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
[TBL] [Abstract][Full Text] [Related]
17. gamma-Hydroxybutyrate intoxication and overdose.
Kohrs FP; Porter WH
Ann Emerg Med; 1999 Apr; 33(4):475-6. PubMed ID: 10092734
[No Abstract] [Full Text] [Related]
18. Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent?
Dean W
Mayo Clin Proc; 2000 Aug; 75(8):872-3. PubMed ID: 10943250
[No Abstract] [Full Text] [Related]
19. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
Dawson AH; Buckley NA
Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
[TBL] [Abstract][Full Text] [Related]
20. [Gamma-hydroxybutyrate, a new central nervous system stimulant].
Strange DG; Jensen D
Ugeskr Laeger; 1999 Dec; 161(50):6934-6. PubMed ID: 10643381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
